# US 2016/0355874 A1 · Multitag sequencing ecogenomics analysis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0355874 A1
- Document ID: US20160355874A1
- Status: Published application
- Kind: A1
- Application number: 15/240,525
- Filed: 2016-08-18
- Published: 2016-12-08
- Earliest claimed: 2006-11-15
- Assignees: Biospherex, LLC
- Applicants: Biospherex, LLC
- Inventors: Patrick M. Gillevet
- Web page: https://patentgrep.com/patent/US20160355874A1

## CPC

- C12Q 1/689: for bacteria
- C12Q 1/6858: Allele-specific amplification
- C12Q 2600/156: Polymorphic or mutational markers
- C12Q 2600/16: Primer sets for multiplex assays
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Embodiments of the invention herein described relate to multiplex polynucleotide sequence analysis without the use of size separation methods or blotting. In certain particulars the invention relates to multiplex sequencing using massively parallel sequencing methods, such as pyrosequencing methods and sequencing by synthesis. The invention provides increased throughput, increased accuracy of enumerating sample components, and the ability to analyze greater numbers of samples simultaneously or serially on presently available systems, as well as others yet to be developed. In certain of its embodiments the invention relates to the analysis of complex microbial communities, particularly to in-depth analysis thereof in large numbers of samples.

## Claims

### Claim 1

A multiplex method for the quantitative determination of polynucleotides in two or more samples, comprising:
hybridizing a first primer to polynucleotides in a first sample, said first primer comprising a first tag sequence and a first probe sequence specific for a first target sequence, wherein said first target sequence is 3′ to a variable genetic region;
elongating primer templates formed thereby to form a first population of tagged polynucleotides comprising: said first primer including said first tag sequence; and sequences of said variable genetic region;
hybridizing a second primer to polynucleotides in a second sample, said second primer comprising a second tag sequence and a second probe sequence specific for a second target sequence, wherein said second target sequence is 3′ to the same variable genetic region as said first target sequence, wherein further said second probe sequence may be the same as or different from said first probe sequence;
elongating primer templates formed thereby to form a second population of tagged polynucleotides comprising: said second primer including said second tag sequence; and sequences of said variable genetic region;
mixing said first and second populations together;
determining sequences of polynucleotides comprising tag sequences and the sequences of the variable genetic element in said mixture;
from the tag sequences comprised in the polynucleotide sequences thus determined identifying the sample in which polynucleotide sequences occurred;
from the sequences of the variable genetic region comprised in the polynucleotide sequences thus determined identifying particular variants of said variable genetic element;
from this information determining the number of time one or more given variants occur in each sample, and
from the number for each variant in the polynucleotides thus determined, quantifying said polynucleotides in said samples;
wherein said sequences are determined without Southern blot transfer and/or without size-separating primer extension products and/or without electrophoresis.

### Claim 2

A multiplex method for the quantitative determination of polynucleotides in two or more samples, comprising:
hybridizing a first primer pair to polynucleotides in a first sample, the first primer of said first primer pair comprising a first tag sequence and a first probe sequences specific for a first target sequence and the second primer of said first primer pair comprising a second tag sequence and a second probe sequence specific for a second target sequence, wherein the first and the second probe sequences flank and hybridize to opposite strands of a variable genetic region;
elongating primer templates formed thereby to from a first population of tagged polynucleotides, each of said polynucleotides comprising: (a) the sequence of said first primer of said first primer pair, a sequence of said variable genetic region, and a sequence complementary to the sequence of said second primer of said first primer pair or (b) a sequence complementary to the sequence of said first primer of said first primer pair, a sequence of said variable genetic region and the sequence of said second primer of said first primer pair;
hybridizing a second primer pair to polynucleotides in a second sample, the first primer of said second primer pair comprising a third tag sequence and said first probe sequences specific for said first target sequence and the second primer of said second primer pair comprising a fourth tag sequence and said second probe sequence specific for said second target sequence;
elongating primer templates formed thereby to from a second population of tagged polynucleotides, each of said polynucleotides comprising: (a) the sequence of said first primer of said second primer pair, a sequence of said variable genetic region, and a sequence complementary to the sequence of said second primer of said second primer pair or (b) a sequence complementary to the sequence of said first primer of said second primer pair, a sequence of said variable genetic region and the sequence of said second primer of said second primer pair;
mixing said first and second populations together;
determining sequences of polynucleotides in said mixture, comprising the tag sequences and the variable genetic element;
from the tag sequences comprised in the polynucleotide sequences thus determined identifying the sample in which polynucleotide sequences occurred;
from the sequences of the variable genetic region comprised in the polynucleotide sequences thus determined identifying particular variants of said variable genetic element;
from this information determining the number of times given variants occur in each sample, and
from the number for each variant in the polynucleotides thus determined, quantifying said polynucleotides in said samples.
wherein said sequences are determined without Southern blot transfer and/or without size-separating primer extension products and/or without electrophoresis.

### Claim 3 (depends on 2)

A method according to claim 2, wherein the number of said polynucleotides in said first sample is any of 5, 10, 25, 50, 100, 150, 200, 250, 500, 1,000, 1,500, 2,000, 2,500, 5,000, 7,500, 10,000, 12,500, 15,000, 17,500, 20,000, 25,000, 30,000, 35,000, 40,000, 50,000, 75,000, 100,000, 150,000, 200,000, 250,000, 500,000, 1,000,000 or more, and the number of said polynucleotides in said second sample is any of 5, 10, 25, 50, 100, 150, 200, 250, 500, 1,000, 1,500, 2,000, 2,500, 5,000, 7,500, 10,000, 12,500, 15,000, 17,500, 20,000, 25,000, 30,000, 35,000, 40,000, 50,000, 75,000, 100,000, 150,000, 200,000, 250,000, 500,000, 1,000,000 or more.

### Claim 4 (depends on 2)

A method according to claim 2, wherein the number of said samples and of said different tags therefor is 5, 10, 15, 20, 25, 50, 75, 100, 150, 200, 250, 500, 1,000, 2,500, 5,000, 10,000 or more.

### Claim 5 (depends on 2)

A method according to claim 2, wherein the tags are nucleotide sequences that are 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36 nucleotides long or any combination thereof.

### Claim 6 (depends on 2)

A method according to claim 2, wherein said tags are comprised in primers for amplification and are incorporated into said polynucleotides by amplification using said primers.

### Claim 7 (depends on 6)

A method according to claim 6, wherein the primer for amplification comprises a sequence for PCR amplification, linear amplification, transcriptional amplification, rolling circle replication, or QB replication.

### Claim 8 (depends on 7)

A method according to claim 7, wherein the primer for amplification comprises a sequence for PCR amplification.

### Claim 9 (depends on 2)

A method according to claim 2, wherein each of said polynucleotides is disposed individually on a bead isolated from other polynucleotides.

### Claim 10 (depends on 2)

A method according to claim 2, wherein each of said polynucleotides is disposed individually on a bead isolated from other said polynucleotides, is amplified while disposed therein, and the amplification products thereof also are disposed on said bead.

### Claim 11 (depends on 2)

A method according to claim 2, wherein each of said polynucleotides is disposed individually on a bead isolated from other said polynucleotides, is amplified while disposed therein, the amplification products thereof also are disposed on said bead, and each said bead is disposed individually in a well isolated from other said beads.

### Claim 12 (depends on 2)

A method according to claim 2, wherein the sequences are determined by pyrosequencing.

### Claim 13 (depends on 2)

A method according to claim 2, wherein said samples are biological samples, each comprising one or more species.

### Claim 14 (depends on 2)

A method according to claim 2, wherein variants of the variable genetic region are specific to particular organisms.

### Claim 15 (depends on 2)

A method according to claim 2, wherein said variable genetic region comprises a variable 16S rRNA sequence, a variable 18S rRNA sequence, a variable rRNA ITS sequence, a mitochondrial sequence, a microsatellite sequence, a metabolic enzyme sequence, and/or a genetic disease sequence.

### Claim 16 (depends on 2)

A method according to claim 2, wherein the samples are microbial community samples.

### Claim 17 (depends on 2)

A method according to claim 2, wherein the samples are microbial community samples for clinical analysis of a patient.

### Claim 18 (depends on 2)

A method according to claim 2, wherein the samples are microbial community environmental samples.

### Claim 19 (depends on 2)

A method according to claim 2, wherein the samples are microbial community soil samples.

### Claim 20 (depends on 2)

A method according to claim 2, wherein the samples are microbial community water samples.

### Claim 21 (depends on 2)

A method according to claim 2, wherein the samples are samples for SNP analysis.

### Claim 22 (depends on 2)

A method according to claim 2, wherein the samples are samples for genotyping.

### Claim 23

A kit comprising a plurality of two or more primers, each primer in said plurality comprising a tag sequence and a probe sequence specific to a target sequence, wherein:
(A) in each of said primers the probe sequence is 3′ to the tag sequence, but not necessarily adjacent thereto;
(B) in each of said primers: the tag sequence is different from the tag sequence of the other in the plurality; the tag sequence is not the complementary sequence to any other tag sequence in the plurality; the tag sequence does not contain any homodinucleotide sequences;
the junction sequences between the tag sequence and the adjacent parts of the primer, if any, is not a homodinucleotide sequence;
(C) in each of said primers the probe sequence is complementary to the target sequence and the target sequence is located 3′ to a variable genetic region, and
(D) each of said primers is disposed separately from the others in containers in said kit.

### Claim 24 (depends on 23)

A kit according to claim 23, wherein each of said primers further comprises a priming sequence 5′ to the tag sequence but not necessarily adjacent thereto, and the priming sequence is the same in all of said primers, said kit further comprising a primer complimentary to and effective for polymerization from said priming sequence.

### Claim 25

A kit comprising a plurality of two or more primers pairs, each primer in said plurality comprising a tag sequence and a probe sequence specific to a target sequence, wherein:
(A) in each of said primer the probe sequence is 3′ to the tag sequence, but not necessarily adjacent thereto;
(B) in each of said primers: the tag sequence is different from the tag sequence of the other in the plurality; the tag sequence is not the complementary sequence to any other tag sequence in the plurality; the tag sequence does not contain any homodinucleotide sequences; the junction sequences between the tag sequence and the adjacent parts of the primer, if any, is not a homodinucleotide sequence;
(C) in each of said primers the probe sequence is complementary to the target sequence,
(D) in each primer pair the probe sequences are specific to target sequences that flank a variable genetic region;
(E) each of said primers is disposed separately from the others in said kit.

### Claim 26 (depends on 25)

A kit according to claim 25, wherein the primers further comprise a priming sequence 5′ to the tag sequence but not necessarily adjacent thereto, the priming sequence either is the same in all the primers, or one member of each pair has the same first priming sequence and the second member of each pair has the same second priming sequence, said kit further comprising disposed separately from one another in one or more containers one or more primers complementary to and effective for elongation from said priming sequence or sequences.
